Cite
[Ticagrelor monotherapy in patients with acute coronary syndrome receiving new generation drug-eluting stents: results of the T-PASS randomized clinical trial].
MLA
Ruggiero, Rossella, et al. “[Ticagrelor Monotherapy in Patients with Acute Coronary Syndrome Receiving New Generation Drug-Eluting Stents: Results of the T-PASS Randomized Clinical Trial].” Giornale Italiano Di Cardiologia (2006), vol. 25, no. 6, June 2024, pp. 41–42. EBSCOhost, https://doi.org/10.1714/4287.42692.
APA
Ruggiero, R., Beneduce, A., Demola, P., Pompei, G., Barioli, A., Ryan, N., Barbato, E., & Toselli, M. (2024). [Ticagrelor monotherapy in patients with acute coronary syndrome receiving new generation drug-eluting stents: results of the T-PASS randomized clinical trial]. Giornale Italiano Di Cardiologia (2006), 25(6), 41–42. https://doi.org/10.1714/4287.42692
Chicago
Ruggiero, Rossella, Alessandro Beneduce, Pierluigi Demola, Graziella Pompei, Alberto Barioli, Nicola Ryan, Emanuele Barbato, and Marco Toselli. 2024. “[Ticagrelor Monotherapy in Patients with Acute Coronary Syndrome Receiving New Generation Drug-Eluting Stents: Results of the T-PASS Randomized Clinical Trial].” Giornale Italiano Di Cardiologia (2006) 25 (6): 41–42. doi:10.1714/4287.42692.